Marketable Securities, Current in USD of Gossamer Bio, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Gossamer Bio, Inc. quarterly Marketable Securities, Current history and change rate from Q4 2018 to Q3 2025.
  • Gossamer Bio, Inc. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $171,291,000.000, a 42.6% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

Gossamer Bio, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $171,291,000 -$127,279,000 -42.6% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $186,609,000 -$81,002,000 -30.3% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $228,913,000 +$23,382,000 +11.4% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $248,444,000 -$15,872,000 -6% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $298,570,000 +$52,291,000 +21.2% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $267,611,000 +$142,489,000 +1.1% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $205,531,000 +$68,917,000 +50.4% 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $264,316,000 +$120,611,000 +83.9% 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 $246,279,000 +$95,373,000 +63.2% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $125,122,000 -$2,723,000 -2.1% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $136,614,000 +$3,898,000 +2.9% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $143,705,000 +$1,890,000 +1.3% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $150,906,000 -$1,640,000 -1.1% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $127,845,000 +$64,379,000 +1% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $132,716,000 +$119,078,000 +8.7% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $141,815,000 +$115,242,000 +4.3% 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $152,546,000 +$59,124,000 +63.3% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $63,466,000 -$50,836,000 -44.5% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $13,638,000 -$221,174,000 -94.2% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $26,573,000 -$240,167,000 -90% 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 $93,422,000 -$222,342,000 -70.4% 30 Sep 2020 10-Q 10 Nov 2020
Q2 2020 $114,302,000 -$201,193,000 -63.8% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 $234,812,000 -$75,562,000 -24.3% 31 Mar 2020 10-Q 12 May 2020
Q4 2019 $266,740,000 +$143,301,000 +1.2% 31 Dec 2019 10-K 26 Feb 2021
Q3 2019 $315,764,000 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $315,495,000 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $310,374,000 31 Mar 2019 10-Q 14 May 2019
Q4 2018 $123,439,000 31 Dec 2018 10-K 24 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.